留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性心肌病诊断新路径:从高分辨影像到分子精准医学

吴炜 王怡宁 代静文 金征宇 张抒扬

吴炜, 王怡宁, 代静文, 金征宇, 张抒扬. 原发性心肌病诊断新路径:从高分辨影像到分子精准医学[J]. 协和医学杂志, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002
引用本文: 吴炜, 王怡宁, 代静文, 金征宇, 张抒扬. 原发性心肌病诊断新路径:从高分辨影像到分子精准医学[J]. 协和医学杂志, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002
Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002
Citation: Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. doi: 10.3969/j.issn.1674-9081.2019.01.002

原发性心肌病诊断新路径:从高分辨影像到分子精准医学

doi: 10.3969/j.issn.1674-9081.2019.01.002
基金项目: 

国家重点研发计划资助项目 2016YFC0901500

国家重点研发计划资助项目 2016YFC0905102

中国医学科学院医学与健康科技创新工程项目 2017-I2M-2-002

详细信息
    通讯作者:

    张抒扬  电话:010-69155068,E-mial:zhangshuyang2018@126.com

  • 中图分类号: R445;R542.2

New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine

More Information
  • 摘要: 原发性心肌病的既往定义是一大类未明原因造成的心肌直接异常, 而非继发于缺血、高血压、糖尿病、甲状腺功能亢进等因素。其临床诊断路径局限于描述心肌损害以后造成的心脏结构与功能异常, 如扩张、肥厚、限制以及收缩性或舒张性心力衰竭等。随着诊断技术的进步, 尤其是高分辨影像技术和分子精准医学的突破性进展, 先前的原发性心肌病定义以及诊断路径已不能满足临床需求。新时代下, 具有条件的大型医学中心应采用新的临床诊断路径, 其内容涵盖高分辨影像与遗传学分析, 可为原发性心肌病提供更为充分的影像与精准医学信息, 并为后续的影像组学分析、基因治疗、靶向药物研发、遗传学咨询等创造条件。
    利益冲突  无
  • [1] Elliott P, Anderson R, Arbustini E, et al.Classification of the cardiomyopathies:a position statement from the european society of cardiology working group on myocardial and pericardial diseases[J].Eur Heart J, 2008, 29:270-276.
    [2] Arbustini E, Narula N, Tavazzi L, et al.The MOGE(S) classification of cardiomyopathy for clinicians[J].J Am Coll Cardiol, 2014, 64:304-318.
    [3] Marchesini M, Uguccioni L, Parisi R, et al.The role of cardiac magnetic resonance imaging in hypertrophic cardiomyopathy[J].Rev Cardiovasc Med, 2016, 17:57-64.
    [4] Kwon DH, Setser RM, Popović ZB, et al.Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy:a delayed contrast enhanced MRI study[J].Int J Cardiovasc Imaging, 2008, 24:617-625.
    [5] Hinojar R, Varma N, Child N, et al.T1 mapping in discrimination of hypertrophic phenotypes:hypertensive heart disease and hypertrophic cardiomyopathy:findings from the international T1 multicenter cardiovascular magnetic resonance study[J].Circ Cardiovasc Imaging, 2015, 8:pii:e003285.
    [6] Sado DM, White SK, Piechnik SK, et al.Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping[J].Circ Cardiovasc Imaging, 2013, 6:392-398.
    [7] Moon JC, Sachdev B, Elkington AG, et al.Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease.Evidence for a disease specific abnormality of the myocardial interstitium[J].Eur Heart J, 2003, 24:2151-2155.
    [8] Maceira AM, Joshi J, Prasad SK, et al.Cardiovascular magnetic resonance in cardiac amyloidosis[J].Circulation, 2005, 111:186-193.
    [9] Ellims AH, Iles LM, Ling LH, et al.A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging:linking genotype with fibrotic phenotype[J].Eur Heart J Cardiovasc Imaging, 2014, 15:1108-1116.
    [10] Gillies RJ, Kinahan PE, Hricak H.Radiomics:images are more than pictures, they are data[J].Radiology, 2016, 278:563-577.
    [11] Sengupta PP, Huang YM, Bansal M, et al.Cognitive machine-learning algorithm for cardiac imaging:A pilot study for differentiating constrictive pericarditis from restrictive cardiomyopathy[J].Circ Cardiovasc Imaging, 2016, 9:pii:e004330.
    [12] Baessler B, Luecke C, Lurz J.Cardiac MRI texture analysis of T1 and T2 maps in patients with infarctlike acute myocarditis[J].Radiology, 2018, 289:357-365.
    [13] Teekakirikul P, Kelly MA, Rehm HL, et al.Inherited cardiomyopathies:molecular genetics and clinical genetic testing in the postgenomic era[J].J Mol Diagn, 2013, 15:158-170.
    [14] Worman HJ, Bonne G."Laminopathies":A wide spectrum of human diseases[J].Exper Cell Res, 2007, 313:2121-2133.
    [15] Berne P, Brugada J.Brugada syndrome 2012[J].Circ J, 2012, 76:1563-1571.
    [16] Millat G, Chanavat V, Rousson R.Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies[J].Clin Chim Acta, 2014, 433:266-271.
    [17] Loman NJ, Misra RV, Dallman TJ, et al.Performance comparison of benchtop high throughput sequencing platforms[J].Nat Biotechnol, 2012, 30:434-439.
    [18] Zhao Y, Feng Y, Zhang YM, et al.Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy[J].Int J Mol Med, 2015, 36:1479-1486.
    [19] Bottillo I, D'Angelantonio D, Caputo V, et al.Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy[J].Gene, 2016, 577:227-235.
    [20] Lu C, Wu W, Liu F, et al.Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequenc-ing technologies[J].J Transl Med, 2018, 16:241.
    [21] Wu W, Lu CX, Wang YN, et al.Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-genera-tion sequencing[J].J Am Heart Assoc, 2015, 4:e001879
    [22] Ruan YP, Lu CX, Zhao XY, et al.Restrictive Card-iomyopathy Resulting from a Troponin I Type 3 Mutation in a Chinese Family[J].Chin Med Sci J, 2016, 31:1-7.
    [23] 徐昊鹏, 朱翀, 弓孟春, 等.中国罕见病研究的现状与未来[J].协和医学杂志, 2018, 9:5-9.
  • 加载中
计量
  • 文章访问数:  525
  • HTML全文浏览量:  62
  • PDF下载量:  188
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-10-04
  • 刊出日期:  2020-02-01

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!